Phytopharm PLC
01 May 2008
1 May 2008
In accordance with the FSA's Disclosure and Transparency Rules sourcebook
transitional provision 6, Phytopharm plc ('Phytopharm') hereby notifies the
market of the following:
Phytopharm's issued share capital at 30 April 2008 consisted of 94,545,977
ordinary shares with voting rights. The Company did not, at that date, hold any
shares in Treasury, and therefore the total number of ordinary shares in the
Company with voting rights was 94,545,977.
The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, Phytopharm plc under the FSA's
Disclosure and Transparency Rules.
Zoe McGowan
Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.